RE:Decision point for mass industrializationExcerpt from the article:
"PGX is a disruptive "green" technology that promises to be a game-changer in drug and bioactive processing and delivery. Addressing a myriad of unmet needs and issues that neutraceutical and pharmaceutical companies grapple with. PGX may make much of what was previously impossible with conventional processing and drying methods possible. "PGX will be of interest to manufacturers looking to increase bioavailability and efficacy, reduce processing steps and carbon footprint, eliminate unwanted ingredients or additives from their formulations, increase stability and shelf-life and/or offer new and innovative delivery systems beyond pills and capsules" says Gagnon.""
prophetoffactz wrote: With PGX anticipated to reach the decision point for mass industrialization in Q3 with commissioning of the 100L scale-up this article is a good reminder of the importance of CZO's game-changing technology.
Biotecanada Insights Fall 2022 by BIOTECanada - Issuu